Researcher
Yong Chen
- Disciplines:Molecular medicine
Affiliations
- Department of Pharmaceutics (Department)
Member
From1 Aug 2019 → Today
Projects
1 - 2 of 2
- HEPTAMETHINE CYANINE-POLY(ETHYLENE GLYCOL) AS MOLECULAR ANCHOR FOR TUMOR TARGETED CYTOKINE DELIVERYFrom1 Oct 2023 → TodayFunding: FWO senior postdoctoral fellowship
- m/mPROTACs : macromolecular multivalent proteolysis targeting chimerasFrom7 Oct 2020 → 30 Sep 2023Funding: BOF - postdoctoral mandates
Publications
1 - 5 of 5
- Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids(2023)
Authors: Alexander Lamoot, Joris Lammens, Emily De Lombaerde, Zifu Zhong, Mark Gontsarik, Yong Chen, Thomas De Beer, Bruno De Geest
Pages: 4327 - 4334 - Lipid nanoparticle delivery alters the adjuvanticity of the TLR9 agonist CpG by innate immune activation in lymphoid tissue(2023)
Authors: Zifu Zhong, Yong Chen, Kim Deswarte, Heleen Lauwers, Emily De Lombaerde, Xiaole Cui, Simon Van Herck, Tingting Ye, Mark Gontsarik, Stefan Lienenklaus, et al.
- Smart hydrogels delivered by high pressure aerosolization can prevent peritoneal adhesions(2023)
Authors: Helena Braet, Peter-Paul Fransen, Yong Chen, Simon Van Herck, Remco Mariën, Valérie Vanhoorne, Wim Ceelen, Annemieke Madder, Steven Ballet, Richard Hoogenboom, et al.
Pages: 138 - 150 - Lipid-polyglutamate nanoparticle vaccine platform(2021)
Authors: Dorien Van Lysebetten, Alessio Malfanti, Kim Deswarte, Kaloian Koynov, Bianka Golba, Tingting Ye, Sabah Kasmi, Alexander Lamoot, Yong Chen, Simon Van Herck, et al.
Pages: 6011 - 6022 - Potent and prolonged innate immune activation by enzyme-responsive imidazoquinoline TLR7/8 agonist prodrug vesicles(2020)
Authors: Bi Wang, Simon Van Herck, Yong Chen, Xiangyang Bai, Kim Deswarte, Niek Sanders, Stefan Lienenklaus, Hans W. Scheeren, Sunil A. David, Fabian Kiessling, et al.
Pages: 12133 - 12139